Chronic exposure to benzene results in a unique form of dysplasia

Leukemia Research

Volumn 29, Issue 12, 2005, Pages 1371-1380

  Irons, Richard D ^a,b   Lv, Ling ^a,c   Gross, Sherilyn A ^a,b   Ye, Xibiao ^a   Bao, Liming ^a,d   Wang, Xiao Qin ^a,c   Ryder, John ^a,b   Armstrong, Thomas W ^e   Zhou, Yimei ^e   Miao, Lizhaung ^a   Le, Anh T ^b   Kerzic, Patrick J ^b   Ni, Weimin ^f   Fu, Hua ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF COLORADO   (United States)

^c FUDAN UNIVERSITY   (China)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

^f Tongji University School of Medicine   (China)

Author keywords

Benzene; Hematotoxicity; Immunopathology; Myelodysplastic syndrome

Indexed keywords

BENZENE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD TOXICITY; BONE MARROW DISEASE; BONE MARROW HYPOPLASIA; CELL GRANULE; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; DYSERYTHROPOIESIS; DYSPLASIA; EOSINOPHIL; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MALE; MYELODYSPLASIA; NEUTROPHIL; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; STROMA; T LYMPHOCYTE; TISSUE DEGENERATION;

ADULT; AUTOIMMUNITY; BENZENE; BLOOD CELLS; BONE MARROW DISEASES; FEMALE; HEMATOLOGIC DISEASES; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PHAGOCYTOSIS; T-LYMPHOCYTES;

EID: 27644486016     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.08.019     Document Type: Article

References (55)

1. A.J. Barrett Myelodysplastic syndrome - an example of misguided immune surveillance? Leuk Res 28 2004 1123 1124
2. C. Rosenfeld, and A. List A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies Leukemia 14 2000 2 8
3. D.H. Biesma, J.G. van den Tweel, and L.F. Verdonck Immunosuppressive therapy for hypoplastic myelodysplastic syndrome Cancer 79 1997 1548 1551
4. T. Matsutani, T. Yoshioka, Y. Tsuruta, T. Shimamoto, J.H. Ohyashiki, and R. Suzuki Determination of T-cell receptors of clonal CD8-positive T-cells in myelodysplastic syndrome with erythroid hypoplasia Leuk Res 27 2003 305 312
5. R.A. Rinsky, A.B. Smith, R.W. Hornung, T.G. Filloon, R.J. Young, and A.H. Okun Benzene and leukemia: an epidemiologic risk assessment N Engl J Med 316 17 1987 1044 1050
6. E.C. Vigliani, and G. Saita Benzene and leukemia N Engl J Med 271 1964 872 876
7. M. Aksoy, K. Dincol, S. Erdem, and G. Dincol Acute leukemia due to chronic exposure to benzene Am J Med 52 1972 160 166
8. F. Fagioli, A. Cuneo, N. Piva, M.G. Carli, R. Previati, and M. Balboni Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents Cancer 70 1992 77 85
9. A. Cuneo, F. Fagioli, I. Pazzi, A. Tallarico, R. Previati, and N. Piva Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents Leuk Res 16 1992 789 796
10. H.M. Golomb, G. Alimena, J.D. Rowley, J.W. Vardiman, J.R. Testa, and C. Sovik Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia Blood 60 1982 404 411
11. G. Ciccone, D. Mirabelli, A. Levis, P. Gavarotti, G. Rege-Cambrin, and L. Davico Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study Cancer Genet Cytogenet 68 1993 135 139
12. E. Browning Toxicity and metabolism of industrial solvents 1965 Elsevier Publishing Company London
13. L. Greenburg, M.R. Mayers, L.J. Goldwater, and A.R. Smith Benzene (benzol) poisoning in the rotogravure printing industry in New York City J Ind Hyg Toxicol 21 8 1939 395 420
14. L.J. Goldwater Disturbances in the blood following exposure to benzol J Lab Clin Med 26 1941 957 973
15. M.S. Linet, S.N. Yin, L.B. Travis, C.Y. Li, Z.N. Zhang, and D.G. Li Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China Environ Health Perspect 104 Suppl. 6 1996 1353 1364
16. E. Jaffe, N. Harris, H. Stein, and J. Vardiman World Health Organization Classification of Tumours P. Kleihues L.H. Sobin Lyon Pathology and genetics of tumours of haematopoietic and lymphoid tissues 2001 IARC Press France
17. U.S. Department of Health and Human Services: Centers for Disease Control, National Institute for Occupational Safety and Health Aromatic Hydrocarbons: Method 1501. Schlecht, P. C. Third supplement to NIOSH manual of analytical methods (NMAM) 4th Cincinnati, OH National Institute for Occupational Safety and Health, DHHS (NIOSH) 2003.
18. L.Y. Shih, C.F. Huang, P.N. Wang, J.H. Wu, T.L. Lin, and P. Dunn Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia Leukemia 18 2004 466 475
19. K. Bagrintseva, R. Schwab, T.M. Kohl, S. Schnittger, S. Eichenlaub, and J.W. Ellwart Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoietic cells Blood 103 2004 2266 2275
20. Y. Yamamoto, H. Kiyoi, Y. Nakano, R. Suzuki, Y. Kodera, and S. Miyawaki Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies Blood 97 2001 2434 2439
21. J.J. van Dongen, A.W. Langerak, M. Bruggemann, P.A. Evans, M. Hummel, and F.L. Lavender Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 Leukemia 17 2003 2257 2317
22. A.V.E.C. Forni Chemical leukemogenesis in man Semin. Hematol. 7 1974 211 223
23. A. Orazi, G. Cattoretti, D. Soligo, R. Luksch, and G. Lambertenghi-Deliliers Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology of the prognostic assessment Leukemia 7 1993 838 847
24. S.M. Smith, M.M. Le Beau, D. Huo, T. Karrison, R.M. Sobecks, and J. Anastasi Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series Blood 102 2003 43 52
25. J. Pedersen-Bjergaard, M.K. Andersen, D.H. Christiansen, and C. Nerlov Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia Blood 99 2002 1909 1912
26. M.M. Crane, S.S. Strom, S. Halabi, E.L. Berman, J.J. Fueger, and M.R. Spitz Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia Cancer Epidemiol Biomarkers Prev 5 1996 639 644
27. E.A. Vandenberghe, C. Mecucci, A. Delannoy, and H. Van den Berghe Deletion of 5q by t(5;17) in therapy-related myelodysplastic syndrome Cancer Genet Cytogenet 48 1990 49 52
28. R.D. Irons, and W.S. Stillman The process of leukemogenesis Environ Health Perspect 104 1996 1239 1246
29. K. Ozeki, H. Kiyoi, Y. Hirose, M. Iwai, M. Ninomiya, and Y. Kodera Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia Blood 103 2004 1901 1908
30. Y. Saunthararajah, R. Nakamura, J.M. Nam, J. Robyn, F. Loberiza, and J.P. Maciejewski HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome Blood 100 2002 1570 1574
31. T.J. Hamblin Immunological abnormalities in myelodysplastic syndromes Semin Hematol 33 1996 150 162
32. Y. Saunthararajah, J.L. Molldrem, M. Rivera, A. Williams, M. Stetler-Stevenson, and L. Sorbara Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: Clinical and pathophysiological features Br J Haematol 112 2001 195 200
33. T. Shimamoto, T. Iguchi, K. Ando, T. Katagiri, T. Tauchi, and Y. Ito Successful treatment with cyclosporin a for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements Br J Haematol 114 2001 358 361
34. H. Kook, W. Zeng, C. Guibin, M. Kirby, N.S. Young, and J.P. Maciejewski Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia Exp Hematol 29 2001 1270 1277
35. A. Jonasova, R. Neuwirtova, J. Cermak, V. Vozobulova, K. Mocikova, and M. Siskova Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow Br J Haematol 100 1998 304 309
36. β profiles Br J Haematol 102 1998 1314 1322
37. J.P. Maciejewski, J.R. Hibbs, S. Anderson, P. Katevas, and N.S. Young Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure Exp Hematol 22 1994 1102 1110
38. J. Barrett Myelodysplastic syndrome and aplastic anemia - diagnostic and conceptual uncertainties [comment] Leuk Res 24 2000 595 596
39. D.P. Steensma, and A. Tefferi The myelodysplastic syndrome(s): a perspective and review highlighting current controversies Leuk Res 27 2003 95 120
40. C. Aul, U. Germing, N. Gattermann, and H. Minning Increasing incidence of myelodysplastic syndromes: real or fictitious? Leuk Res 22 1998 93 100
41. M.L. Heaney, and D.W. Golde Myelodysplasia N Engl J Med 340 1999 1649 1660
42. - bone marrow cells Exp Hematol 28 2000 169 176
43. M.T. Smith, L.P. Zhang, M. Jeng, Y.X. Wang, W.H. Guo, and P. Duramad Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells Carcinogenesis 21 2000 1485 1490
44. M.T. Smith, L.P. Zhang, Y.X. Wang, R.B. Hayes, G.L. Li, and J. Wiemels Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene Cancer Res 58 1998 2176 2181
45. M.B. Jordan, D. Hildeman, J. Kappler, and P. Marrack An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder Blood 104 2004 735 743
46. C.L. O'Keefe, M. Plasilova, M. Wlodarski, A.M. Risitano, A.R. Rodriguez, and E. Howe Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses J Immunol 172 2004 1960 1969
47. M.F. Callan, C. Fazou, H. Yang, T. Rostron, K. Poon, and C. Hatton CD8(+) T-cell selection, function, and death in the primary immune response in vivo J Clin Invest 106 2000 1251 1261
48. Y.S. Hahn, C. Taube, N. Jin, L. Sharp, J.M. Wands, and M.K. Aydintug Different potentials of gamma delta T cell subsets in regulating airway responsiveness: V gamma 1+ cells, but not V gamma 4+ cells, promote airway hyperreactivity, Th2 cytokines, and airway inflammation J Immunol 172 2004 2894 2902
49. A. Kanehiro, M. Lahn, M.J. Makela, A. Dakhama, M. Fujita, and A. Joetham Tumor necrosis factor-alpha negatively regulates airway hyperresponsiveness through gamma-delta T cells Am J Respir Crit Care Med 164 2001 2229 2238
50. R.D. Irons, W.S. Stillman, D.B. Colagiovanni, and V.A. Henry Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro Proc Natl Acad Sci USA 89 1992 3691 3695
51. R.D. Irons, and W.S. Stillman Cell proliferation and differentiation in chemical leukemogenesis Stem Cells 11 1993 235 242
52. R.D. Irons, and W.S. Stillman Impact of benzene metabolites on differentiation of bone marrow progenitor cells Environ Health Perspect 104 Suppl. 6 1996 1247 1250
53. J.H. Zheng, D.W. Pyatt, S.A. Gross, A.T. Le, P.J. Kerzic, and R.D. Irons Hydroquinone modulates the GM-CSF signaling pathway in TF-1 cells Leukemia 2004 1 9
54. P.J. Kerzic, D.W. Pyatt, J.H. Zheng, S.A. Gross, A. Le, and R.D. Irons Inhibition of NF-kappaB by hydroquinone sensitizes human bone marrow progenitor cells to TNF-alpha-induced apoptosis Toxicology 187 2003 127 137
55. W. Jiang, L. Kang, H.Z. Lu, X. Pan, Q. Lin, and Q. Pan Normal values for Cd4 and Cd8 lymphocyte subsets in healthy Chinese adults from Shanghai Clin Diagn Lab Immunol 11 2004 811 813